Johnson & Johnson reports first-quarter earnings Tuesday before the bell.
Johnson & Johnson reports first-quarter earnings before the market opens on Tuesday as it faces litigation over its talc baby powder and new competition against its prostate cancer drug Zytiga.J&J makes everything from prescription drugs, soap and surgical staplers, though pharmaceuticals account for about half of the health-care company's revenue.
Sales of prostrate cancer drug Zytiga are under threat, thanks to generic versions launching late last year after a judge struck down J&J's patent. The Food and Drug Administration in March approved a new J&J drug, Spravato, a nasal spray for treatment-resistant depression made from a ketamine-like drug.
A Reuters report in December claimed J&J knew for decades its talc baby powder contained asbestos, threatening the company's namesake portfolio of baby products after relaunching the brand last spring. The company has repeatedly denied any wrongdoing and stands behind its namesake baby powder.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
JP Morgan Chase is set to report first-quarter earnings – here's what the Street expectsBank stocks under-performed the broader market in the first quarter after the Federal Reserve said in March that it was pausing rate hikes for the remainder of the year.
Consulte Mais informação »
Goldman Sachs is set to report first-quarter earnings — here's what the Street expectsIt's only Goldman Sachs CEO David Solomon's second quarter running the bank, but analysts will have plenty of questions for him.
Consulte Mais informação »
Here's what to expect from Wells Fargo's first-quarter earningsWells Fargo is scheduled to release its first-quarter results later on Friday.
Consulte Mais informação »
Chipmakers have surged this year, but first-quarter earnings reports might really disappointSemiconductor stocks, up sharply this year on hopes for a China trade deal, could face their day of reckoning during earnings season.
Consulte Mais informação »
J.P. Morgan Reports Earnings Rose in First QuarterThe nation’s largest bank by assets, JPMorgan Chase reported its first quarter results, giving a glimpse on how the economy’s latest turns have affected big banks.
Consulte Mais informação »
Johnson & Johnson wins U.S. FDA approval for bladder cancer drugJohnson & Johnson's drug Balversa won U.S. approval as the first targeted t...
Consulte Mais informação »
Perspective | Magic Johnson’s stunning bombshell was classic Magic JohnsonThe Hall of Famer hadn't told owner/president Jeanie Buss of his decision and said he wants to just have fun again. The Lakers evidently were not fun.
Consulte Mais informação »
Johnson & Johnson's stock rises after profit and sales beat, raised sales guidanceShares of Johnson & Johnson gained 1.0% in premarket trade Tuesday, after the drug and consumer products giant reported first-quarter earnings and...
Consulte Mais informação »
Delta's first-quarter earnings, revenue beat Wall Street expectationsInvestors were expecting a strong quarter from Delta, especially after it raised its earnings and revenue guidance last week.
Consulte Mais informação »
Earnings season is upon us — here's what to expectFirst-quarter earnings for the S&P 500 are projected to decline 2.5% year over year, according to Refinitiv consensus estimates.
Consulte Mais informação »